Page 178 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Clinical (Epidemiology, Diagnosis) (Cont.)

P0334 COMPUTER-TOMOGRAPHY (CT) WITH MAPPING OF
THE ARTERIAL ENHANCEMENT FRACTION (AEF) FOR
SCREENING OF HEPATOCELLULAR CARCINOMA (HCC) IN
PATIENTS WITH END-STAGE LIVER CIRRHOSIS
Andreas Christe*, Lukas Ebner, Johannes Heverhagen, Adrian Huber,
Switzerland

P0335 SERUM LONG CHAIN CERAMIDES, SPHINGOSINE AND
SPHINGOSINE-1-PHOSPHATE AS NOVEL DIAGNOSTIC
MARKERS IN PATIENTS WITH HEPATOCELLULAR
CARCINOMA
Georgios Grammatikos*, Niklas Schoell, Nerea Ferreiros, Dimitra Bon,
Eva Herrmann, Harald Farnik, Stefan Zeuzem, Bernd Kronenberger,
Oliver Waidmann, Josef Pfeilschifter, Germany

P0336 IMPACT OF GENETIC VARIANTS OF TUMOR NECROSIS
FACTOR LOCUS ON HEPATOCELLULAR CARCINOMA
ePOSTERS SURVIVAL
J.-F. Tsai*, Z.-Y. Lin, S.-C. Chen, W.-L. Chuang, M.-L,Yu, C.-Y, Dai,
Taiwan

P0337 A POLYMORPHISM IN IFNL3 IS AN INDEPENDENT
RISK FACTOR DEVELOPMENT OF HEPATOCELLULAR
CARCINOMA AFTER TREATMENT OF HCV INFECTION
Kuo-Chin Chang*, Po-Lin Tseng, Hung-Chao Hung, Ming-Tsung Lin,Tsung-
Hui Hu, Taiwan

P0338 SURVIVAL POST SORAFENIB IN HEPATOCELLULAR
CARCINOMA: ARE AFP NON-SECRETORS A DISTINCT SUB-
GROUP?
Mehran Afshar*, Helen Clarke, Abigail Jackson-Wilding, Ali Ahmed,
Yuk Ting Ma, Pankaj Punia, The United Kingdom

P0340 CLINICAL PATTERNS OF HEPATOCELLULAR CARCINOMA
(HCC) IN NON ALCOHOLIC FATTY LIVER DISEASE
(NAFLD): A MULTICENTER CASE-CONTROL STUDY
Fabio Piscaglia, Gianluca Svegliati Baroni, Andrea Barchetti,
Anna Pecorelli, Sara Marinelli, Claudio Tiribelli, Stefano Bellentani*,
Italy

178 The International Liver Congress™ 2015 • ILC Programme